When Should Asymptomatic Persons Be Tested for COVID-19?


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
17 12 2020
Historique:
pubmed: 8 10 2020
medline: 29 12 2020
entrez: 7 10 2020
Statut: epublish

Résumé

On 24 August 2020, the Centers for Disease Control and Prevention (CDC) updated its website to highlight that asymptomatic individuals, even those with exposure to a COVID-19-positive contact, do not necessarily need to be tested unless they have medical conditions associated with increased risk of severe illness from COVID-19. The CDC subsequently updated its guidance on 19 September 2020 to support testing of asymptomatic persons, including close contacts of persons with documented SARS-CoV-2 infection. In this editorial, the American Society for Microbiology Clinical and Public Health Microbiology Committee's Subcommittee on Laboratory Practices comments on testing of asymptomatic individuals relative to current medical knowledge of the virus and mitigation measures. Specific points are provided concerning such testing when undertaking contact tracing and routine surveillance. Limitations to consider when testing asymptomatic persons are covered, including the need to prioritize testing of contacts of positive COVID-19 cases. We urge the CDC to consult with primary stakeholders of COVID-19 testing when making such impactful changes in testing guidance.

Identifiants

pubmed: 33023910
pii: JCM.02563-20
doi: 10.1128/JCM.02563-20
pmc: PMC7771439
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

The COVID Tracking Project. 2020.
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, Mo X, Chen Y, Liao B, Chen W, Hu F, Zhang Q, Zhong M, Wu Y, Zhao L, Zhang F, Cowling BJ, Li F, Leung GM. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:672–675.
doi: 10.1038/s41591-020-0869-5
Furukawa NW, Brooks JT, Sobel J. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerg Infect Dis. 2020;26:e201595.
doi: 10.3201/eid2607.201595
Chau NVV, Thanh Lam V, Thanh Dung N, Yen LM, Minh NNQ, Hung LM, Ngoc NM, Dung NT, Man DNH, Nguyet LA, Nhat LTH, Nhu LNT, Ny NTH, Hong NTT, Kestelyn E, Dung NTP, Xuan TC, Hien TT, Thanh Phong N, Tu TNH, Geskus RB, Thanh TT, Thanh Truong N, Binh NT, Thuong TC, Thwaites G, Tan LV. The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. Clin Infect Dis. 2020.
doi: 10.1093/cid/ciaa711
Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin HP, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382:2081–2090.
doi: 10.1056/NEJMoa2008457
Bae SH, Shin H, Koo HY, Lee SW, Yang JM, Yon DK. Asymptomatic transmission of SARS-CoV-2 on evacuation flight. Emerg Infect Dis. 2020.
doi: 10.3201/eid2611.203353
Emery JC, Russell TW, Liu Y, Hellewell J, Pearson CA, CMMID COVID-19 Working GroupKnight GM, Eggo RM, Kucharski AJ, Funk S, Flasche S, Houben RM. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. Elife. 2020;9:e58699.
doi: 10.7554/eLife.58699
Goldberg SA, Lennerz J, Klompas M, Mark E, Pierce VM, Thompson RW, Pu CT, Ritterhouse LL, Dighe A, Rosenberg ES, Grabowski DC. Presymptomatic transmission of SARS-CoV-2 amongst residents and staff at a skilled nursing facility: results of real-time PCR and serologic testing. Clin Infect Dis. 2020.
doi: 10.1093/cid/ciaa991
Lu J, Gu J, Li K, Xu C, Su W, Lai Z, Zhou D, Yu C, Xu B, Yang Z. COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020. Emerg Infect Dis. 2020;26:1628–1631.
doi: 10.3201/eid2607.200764
Qian G, Yang N, Ma AHY, Wang L, Li G, Chen X, Chen X. COVID-19 transmission within a family cluster by presymptomatic carriers in China. Clin Infect Dis. 2020;71:861–862.
doi: 10.1093/cid/ciaa316
Overview of testing for SARS-CoV-2 (COVID-19). 2020.
Overview of testing for SARS-CoV-2 (COVID-19. 2020.
Macke BA, Maher JE. Partner notification in the United States: an evidence-based review. Am J Prev Med. 1999;17:230–242.
doi: 10.1016/s0749-3797(99)00076-8
Swanson KC, Altare C, Wesseh CS, Nyenswah T, Ahmed T, Eyal N, Hamblion EL, Lessler J, Peters DH, Altmann M. Contact tracing performance during the Ebola epidemic in Liberia, 2014–2015. PLoS Negl Trop Dis. 2018;12:e0006762.
doi: 10.1371/journal.pntd.0006762
Lin C, Braund WE, Auerbach J, Chou J-H, Teng J-H, Tu P, Mullen J. Policy decisions and use of information technology to fight coronavirus disease. Emerg Infect Dis. 2020;26:1506–1512.
doi: 10.3201/eid2607.200574
Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020;27:taaa039.
doi: 10.1093/jtm/taaa039
Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, Liang P, Xu Y, Zhang C, Xu A. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16–23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study. J Infect. 2020;80:e1–e13.
doi: 10.1016/j.jinf.2020.03.006
Al-Sadeq DW, Nasrallah GK. The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review. Int J Infect Dis. 2020;98:372–380.
doi: 10.1016/j.ijid.2020.06.098
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173:362–367.
doi: 10.7326/M20-3012
Danis K, Epaulard O, Benet T, Gaymard A, Campoy S, Botelho-Nevers E, Bouscambert-Duchamp M, Spaccaferri G, Ader F, Mailles A, Boudalaa Z, Tolsma V, Berra J, Vaux S, Forestier E, Landelle C, Fougere E, Thabuis A, Berthelot P, Veil R, Levy-Bruhl D, Chidiac C, Lina B, Coignard B, Saura C. Cluster of coronavirus disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis. 2020;71:825–832.
doi: 10.1093/cid/ciaa424
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen H-L, Peiris M, Wu J. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179.
doi: 10.1056/NEJMc2001737
Jung CY, Park H, Kim DW, Choi YJ, Kim SW, Chang TI. Clinical characteristics of asymptomatic patients with COVID-19: a nationwide cohort study in South Korea. Int J Infect Dis. 2020;99:266–268.
doi: 10.1016/j.ijid.2020.08.001
Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323:1406–1407.
doi: 10.1001/jama.2020.2565
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X. Author correction: temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26:1491–1493.
doi: 10.1038/s41591-020-1016-z
Koetter P, Pelton M, Gonzalo J, Du P, Exten C, Bogale K, Buzzelli L, Connolly M, Edel K, Hoffman A, Legro NR, Medina D, Sood N, Blaker J, Kearcher K, Sciamanna C. Implementation and process of a COVID-19 contact tracing initiative: leveraging health professional students to extend the workforce during a pandemic. Am J Infect Control. 2020.
doi: 10.1016/j.ajic.2020.08.012
Infectious Diseases Society of America guidelines on the diagnosis of COVID-19. 2020.
Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe NJamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R. Disease control priorities: improving health and reducing poverty. 2017;315–346.
Testing for COVID-19: a way to lift confinement restrictions. 2020.
Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, Young J, Pereira-Dias J, Hamilton WL, Ferris M, Torok ME, Meredith L, The CITIID-NIHR COVID-19 BioResource CollaborationCurran MD, Fuller S, Chaudhry A, Shaw A, Samworth RJ, Bradley JR, Dougan G, Smith KGC, Lehner PJ, Matheson NJ, Wright G, Goodfellow IG, Baker S, Weekes MP. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. Elife. 2020;9:e58728.
doi: 10.7554/eLife.58728
Davlantes E, Toro M, Villalobos R, Sanchez-Gonzalez L. Notes from the field: COVID-19 prevention practices in state prisons—Puerto Rico, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1144.
doi: 10.15585/mmwr.mm6933a4
Cheng S-Y, Wang CJ, Shen AC-T, Chang S-C. How to safely reopen colleges and universities during COVID-19: experiences from Taiwan. Ann Intern Med. 2020.
doi: 10.7326/M20-2927
De Simone A, Piangerelli M. A Bayesian approach for monitoring epidemics in presence of undetected cases. Chaos Solitons Fractals. 2020;140:110167.
doi: 10.1016/j.chaos.2020.110167
Pearce N, Vandenbroucke JP, VanderWeele TJ, Greenland S. Accurate statistics on COVID-19 are essential for policy guidance and decisions. Am J Public Health. 2020;110:949–951.
doi: 10.2105/AJPH.2020.305708
Wilson E, Donovan CV, Campbell M, Chai T, Pittman K, Sena AC, Pettifor A, Weber DJ, Mallick A, Cope A, Porterfield DS, Pettigrew E, Moore Z. Multiple COVID-19 clusters on a university campus - North Carolina, August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1416–1418.
doi: 10.15585/mmwr.mm6939e3
UNC-Chapel Hill CV-19 dashboard. 2020.
Duke COVID testing tracker. 2020.
University of Illinois Urbana-Champaign COVID testing data. 2020.
Emergency situations (medical devices). Coronavirus (COVID-19) and medical devices. FAQs on testing for SARS-CoV-2. 2020.
Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity - a strategy for containment. N Engl J Med. 2020.
doi: 10.1056/NEJMp2025631
Pettengill MA, McAdam AJ. Can we test our way out of the COVID-19 pandemic?. J Clin Microbiol. 2020.
doi: 10.1128/JCM.02225-20

Auteurs

Audrey N Schuetz (AN)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Peera Hemarajata (P)

Public Health Laboratories, LA County Department of Public Health, Downey, California, USA.

Ninad Mehta (N)

Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Sheldon Campbell (S)

Department of Laboratory Medicine, Yale School of Medicine, West Haven, Connecticut, USA.
Pathology and Laboratory Medicine, VA Connecticut Health Care, West Haven, Connecticut, USA.

Stephanie Mitchell (S)

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Elizabeth Palavecino (E)

Department of Pathology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.

Susan Butler-Wu (S)

Department of Pathology, Keck School of Medicine of USC, Los Angeles, California, USA.

Melissa B Miller (MB)

Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA Melissa.Miller@unchealth.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH